The study design of PIMIDES, a trial based on patient-individualized transcranial electric neurostimulation of epileptic foci, is reported. Inclusion criteria include a predominant epileptic focus and pharmacoresistance to two antiepileptic drug treatments. The study is prospective, unblinded, and serves to assess the safety of subgaleal implantation and transcranial stimulation.
CITATION STYLE
Kravalis, K., & Schulze-Bonhage, A. (2020). PIMIDES I: A pilot study to assess the feasibility of patient-controlled neurostimulation with the EASEE® system to treat medically refractory focal epilepsy. Neurological Research and Practice, 2(1). https://doi.org/10.1186/s42466-020-00061-5
Mendeley helps you to discover research relevant for your work.